^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

REC-4881

i
Company:
Recursion Pharma, Takeda
Drug class:
MEK1 inhibitor, MEK2 inhibitor
Phase 2
Recursion Pharmaceuticals Inc.
Recruiting
Last update posted :
02/06/2024
Initiation :
01/15/2024
Primary completion :
01/01/2027
Completion :
01/01/2027
APC • RAS • AXIN1
|
APC mutation
|
REC-4881